Clinical trialNCT02784444CompletedPhase 2Interventional

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

SponsorCirius Therapeutics, Inc.Enrollment392NASH - Nonalcoholic SteatohepatitisNon-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized, double-blinded study of three doses of MSDC-0602K or placebo given orally once daily to subjects with biopsy proven NASH with fibrosis and no cirrhosis.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Howard Dittrich, MD
Cirius Therapeutics, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Chandler, Arizona, United States
Facility name not stated
Tucson, Arizona, United States
Facility name not stated
Chula Vista, California, United States
Facility name not stated
Fresno, California, United States
Facility name not stated
Garden Grove, California, United States
Facility name not stated
Huntington Park, California, United States
Facility name not stated
La Mesa, California, United States
Facility name not stated
Los Angeles, California, United States
Facility name not stated
Los Angeles, California, United States
Facility name not stated
Poway, California, United States
Facility name not stated
Rialto, California, United States
Facility name not stated
San Diego, California, United States
Facility name not stated
Englewood, Colorado, United States
Facility name not stated
Gainesville, Florida, United States
Facility name not stated
Hialeah, Florida, United States
Facility name not stated
Inverness, Florida, United States
Facility name not stated
Lakewood Rch, Florida, United States
Facility name not stated
Miami Lakes, Florida, United States
Facility name not stated
Wellington, Florida, United States
Facility name not stated
Marietta, Georgia, United States
Facility name not stated
Indianapolis, Indiana, United States
Facility name not stated
Bastrop, Louisiana, United States
Facility name not stated
New Orleans, Louisiana, United States
Facility name not stated
New Orleans, Louisiana, United States
Facility name not stated
West Monroe, Louisiana, United States
Facility name not stated
Flowood, Mississippi, United States
Facility name not stated
Brooklyn, New York, United States
Facility name not stated
New York, New York, United States
Facility name not stated
Fayetteville, North Carolina, United States
Facility name not stated
Greenville, North Carolina, United States
Facility name not stated
Statesville, North Carolina, United States
Facility name not stated
Providence, Rhode Island, United States
Facility name not stated
Germantown, Tennessee, United States
Facility name not stated
Hermitage, Tennessee, United States
Facility name not stated
Arlington, Texas, United States
Facility name not stated
Dallas, Texas, United States
Facility name not stated
Fort Sam Houston, Texas, United States
Facility name not stated
Houston, Texas, United States
Facility name not stated
Live Oak, Texas, United States
Facility name not stated
Rollingwood, Texas, United States

3 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MSDC-0602KPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Sept 2016
Primary completion: 30 Jun 2019
Completion: 30 Jun 2019
Last update posted: 16 Sept 2020
Registered enrollment: 392
Registry id: NCT02784444

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.